X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2025-06-30 | FRHC | Freedom Holding Corp. | Lukyanov Sergey | *See Remarks | P - Purchase | $145.21 | +6,900 | 126,700 | +6% | +$1,001,974 | |||||
2025-06-30 | XOMA | Xoma Royalty Corp | Sitko Bradley | Chief Investment Officer | P - Purchase | $25.39 | +2,000 | 25,029 | +9% | +$50,780 | ||||||
D | 2025-06-30 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $2.08 | +24,096 | 165,862 | +17% | +$49,999 | |||||
2025-07-02 | EXOZ | Exozymes Inc. | Heltzen Michael | CEO | P - Purchase | $10.22 | +1,040 | 10,629 | +11% | +$10,629 | ||||||
D | 2025-06-30 | BCDA | Biocardia, Inc. | McClung David | CFO | P - Purchase | $2.08 | +4,819 | 47,950 | +11% | +$9,999 | |||||
2025-07-01 | CALC | Calcimedica, Inc. | Stauderman Kenneth A. | Chief Scientific Officer | P - Purchase | $1.85 | +1,000 | 12,944 | +8% | +$1,850 | ||||||
2025-07-02 | AUBN | Auburn National Bancorporation, Inc | O'Donnell Shannon | SVP | P - Purchase | $24.06 | +30 | 1,512 | +2% | +$722 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |